apomorphine has been researched along with epidermal growth factor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Namba, H; Nawa, H; Sotoyama, H; Takei, N | 1 |
Aldana, L; Berlanga, J; Garcia Del Barco, D; Perez-Saad, H; Subiros, N | 1 |
2 other study(ies) available for apomorphine and epidermal growth factor
Article | Year |
---|---|
Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Apomorphine; Behavior, Animal; Brain; Cyclic AMP Response Element-Binding Protein; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gait; Hippocampus; Inhibition, Psychological; Phosphorylation; Prefrontal Cortex; Psychomotor Performance; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Startle | 2007 |
Neuroprotective effect of epidermal growth factor in experimental acrylamide neuropathy: an electrophysiological approach.
Topics: Acrylamide; Action Potentials; Animals; Apomorphine; Disease Models, Animal; Dopamine Agonists; Electric Stimulation; Epidermal Growth Factor; Hand Strength; Male; Mice; Mice, Inbred C57BL; Neurologic Examination; Neuroprotective Agents; Penile Erection; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Time Factors | 2017 |